2011
DOI: 10.1016/j.juro.2011.01.014
|View full text |Cite
|
Sign up to set email alerts
|

Salvage Dextranomer-Hyaluronic Acid Copolymer for Persistent Reflux After Ureteral Reimplantation: Early Success Rates

Abstract: Dextranomer-hyaluronic acid copolymer injection is an efficacious salvage procedure for persistent reflux after ureteral reimplantation. The success rate is inferior for ureteral abnormalities other than primary vesicoureteral reflux and after tapering.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…Several groups have suggested endoscopic management since it avoids the challenges of re-operative reimplantation. 1012 Reported success rates for a single dextranomer/hyaluronic acid (DHA) injection for persistent VUR following reimplantation range from 70–83%. 1012 Lower DHA success rates have been reported in patients with an initial diagnosis other than primary VUR, in those with persistent voiding dysfunction prior to injection and following tapered reimplantation.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Several groups have suggested endoscopic management since it avoids the challenges of re-operative reimplantation. 1012 Reported success rates for a single dextranomer/hyaluronic acid (DHA) injection for persistent VUR following reimplantation range from 70–83%. 1012 Lower DHA success rates have been reported in patients with an initial diagnosis other than primary VUR, in those with persistent voiding dysfunction prior to injection and following tapered reimplantation.…”
Section: Discussionmentioning
confidence: 99%
“…1012 Reported success rates for a single dextranomer/hyaluronic acid (DHA) injection for persistent VUR following reimplantation range from 70–83%. 1012 Lower DHA success rates have been reported in patients with an initial diagnosis other than primary VUR, in those with persistent voiding dysfunction prior to injection and following tapered reimplantation. 1011 Various hypotheses have been suggested to explain why persistent VUR occurs following reimplantation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Because of these properties, glycosaminoglycans are currently used under various conditions to rehydrate the skin (Gold 2007; Beasley et al 2009; Redbord et al 2011). New suggestions come for the treatment of the vesicoureteral reflux with glycosaminoglycans (Molitierno et al 2008; Bar-Yosef et al 2011) or fecal incontinence (Graf et al 2011).…”
Section: Discussionmentioning
confidence: 99%